FFN
ATOS icon

Focus Financial Network’s Atossa Therapeutics ATOS Stock Holding History

Focus Financial Network’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-690
Closed -$6.11K – 733
2025
Q4 		$6.11K Buy
690
+13
+2% +$164 ﹤0.01% 725
2025
Q3 		$8.8K Hold
677
– – ﹤0.01% 737
2025
Q2 		$8.43K Hold
677
– – ﹤0.01% 703
2025
Q1 		$6.83K Buy
+677
New +$8.22K ﹤0.01% 684

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Focus Financial Network's ATOS Position: Q1 2026 in Review

Focus Financial Network sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 690 shares — an estimated $6.11K sold.

Focus Financial Network first reported a position in ATOS in Q1 2025 and held it in 4 quarters. The position peaked at $8.8K in Q3 2025. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • Focus Financial Network reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Focus Financial Network sold 690 Atossa Therapeutics shares in Q1 2026, an estimated $6.11K.
  • Focus Financial Network first reported a position in Atossa Therapeutics in Q1 2025 and held it in 4 quarters.
  • Focus Financial Network's Atossa Therapeutics position peaked at $8.8K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on Focus Financial Network's 13F filing for Q1 2026, filed 14 Apr 2026.